To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04641078
Title Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer (DART)
Acronym DART
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University Hospital, Ghent
Indications
Therapies
Age Groups: adult | senior
Covered Countries BEL


No variant requirements are available.